Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




High Omega-3 in Blood Boosts Prostate Cancer Risk

By HospiMedica International staff writers
Posted on 23 Aug 2011
Men with high blood levels of docosahexaenoic acid (DHA), an inflammation-lowering omega-3 (ω3) fatty acid commonly found in fatty fish, have more than double the risk of developing aggressive, high-grade prostate cancer, according to a new study.

Researchers at Fred Hutchinson Cancer Research Center (Seattle, WA, USA) conducted a nested case-control analysis of 3,461 patients (age 55-84 years) participating in the US national Prostate Cancer Prevention Trial in the period 1994-2003. More...
The 1,658 study cases were frequency matched to 1,803 controls by age, treatment, and prostate cancer family history. Phospholipid fatty acids were extracted from serum, and concentrations of ω3, ω6, and trans-fatty acids (TFAs) were expressed as proportions of the total. Estimated odds ratios were calculated for associations of fatty acids with prostate cancer by grade.

The results showed that DHA was positively associated with high-grade disease. Conversely, men with the highest blood ratios of TFAs--which are linked to inflammation and heart disease and abundant in processed foods that contain partially hydrogenated vegetable oils--had a 50% reduction in the risk of high-grade prostate cancer. The researchers also found that ω6 fatty acids, which are found in most vegetable oils and are linked to inflammation and heart disease, were not associated with prostate cancer risk; and none of the fats was associated with the risk of low-grade prostate cancer. The mechanisms behind the impact of ω3 on risk of high-grade prostate cancer are unknown. The study was published in the June 15, 2011, issue of the American Journal of Epidemiology.

“We were stunned to see these results and we spent a lot of time making sure the analyses were correct,” said lead author Theodore Brasky, PhD, a postdoctoral research fellow in the health sciences division. “Our findings turn what we know – or rather what we think we know – about diet, inflammation, and the development of prostate cancer on its head and shine a light on the complexity of studying the association between nutrition and the risk of various chronic diseases.”

Omega-3s are essential unsaturated fatty acids with a double bond (C=C) starting after the third carbon atom from the end of the carbon chain. They cannot be synthesized by the human body but are vital for normal metabolism. Nutritionally important ω3 fatty acids include α-linolenic acid (ALA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA), all of which are polyunsaturated. Common sources of ω3 fatty acids include fish oils and some plant oils such as flaxseed oil and algal oil.

Related Links:

Fred Hutchinson Cancer Research Center



Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
IV Therapy Cart
Avalo I.V Therapy Cart
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.